0001209191-23-032290.txt : 20230525 0001209191-23-032290.hdr.sgml : 20230525 20230525185457 ACCESSION NUMBER: 0001209191-23-032290 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230524 FILED AS OF DATE: 20230525 DATE AS OF CHANGE: 20230525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kozick Linda CENTRAL INDEX KEY: 0001782274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 23962513 MAIL ADDRESS: STREET 1: C/O RAPT THERAPEUTICS, INC. STREET 2: 561 ECCLES AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-24 0 0001673772 RAPT Therapeutics, Inc. RAPT 0001782274 Kozick Linda C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 0 Stock Option (right to buy) 20.93 2023-05-24 4 A 0 12940 0.00 A 2033-05-23 Common Stock 12940 12940 D The Option shall vest on the earlier of (i) May 24, 2024, or (ii) one day prior to the date of the Issuer's next annual meeting of stockholders to be held in 2024, subject to the Reporting Person's continuous service through each applicable vesting date. /s/ Rodney Young, Attorney-in-Fact for Linda Kozick 2023-05-25